OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 35 filers reported holding OPIANT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,364,000 | -10.4% | 126,978 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $1,523,000 | -38.9% | 126,978 | +9.0% | 0.01% | -20.0% |
| Q1 2022 | $2,494,000 | +3.2% | 116,478 | +62.0% | 0.01% | +11.1% |
| Q4 2021 | $2,417,000 | +45.9% | 71,916 | +11.6% | 0.01% | +50.0% |
| Q3 2021 | $1,657,000 | +119.5% | 64,441 | +14.2% | 0.01% | +100.0% |
| Q2 2021 | $755,000 | +18.9% | 56,426 | -5.7% | 0.00% | +50.0% |
| Q1 2021 | $635,000 | +29.9% | 59,831 | -1.7% | 0.00% | 0.0% |
| Q4 2020 | $489,000 | +5.4% | 60,840 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $464,000 | +58.4% | 62,048 | +90.8% | 0.00% | +100.0% |
| Q2 2020 | $293,000 | +270.9% | 32,521 | +300.1% | 0.00% | – |
| Q1 2020 | $79,000 | +276.2% | 8,128 | +439.7% | 0.00% | – |
| Q4 2019 | $21,000 | -52.3% | 1,506 | -39.0% | 0.00% | – |
| Q3 2018 | $44,000 | -52.2% | 2,470 | -61.5% | 0.00% | – |
| Q2 2018 | $92,000 | -52.6% | 6,418 | -36.6% | 0.00% | -100.0% |
| Q1 2018 | $194,000 | +11.5% | 10,117 | +33.5% | 0.00% | 0.0% |
| Q4 2017 | $174,000 | – | 7,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 210,000 | $2,518,000 | 5.80% |
| APIS CAPITAL ADVISORS, LLC | 196,000 | $2,350,000 | 2.65% |
| Stonepine Capital Management, LLC | 152,278 | $1,826,000 | 0.85% |
| Parkman Healthcare Partners LLC | 75,632 | $907,000 | 0.33% |
| PERRITT CAPITAL MANAGEMENT INC | 30,500 | $366,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 50,405 | $604,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 126,978 | $1,523,000 | 0.01% |
| Trexquant Investment LP | 12,219 | $147,000 | 0.01% |
| Renaissance Technologies | 193,415 | $2,319,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 74,400 | $892,000 | 0.00% |